If you are a regular reader of our blog, you know we use a number of terms quite often. Fiercely unbiased. Critical appraisal. Scientific rigor.
But whether you’re a payer or a provider, a current or potential client: what does any of that mean to you? Why are these terms important, and how can the fact that they make up the DNA of what we do enhance your coverage policy determination and value analysis and value-based purchasing initiatives?
Evidence vs “Evidence Lite”
We know we are not the only “game in town” when it comes to claiming to provide healthcare evidence. Where we are truly unique, where we lead the field, is with regard to the quality of the evidence analysis we provide. We do not just review abstracts. We do not only rely on case studies and reports. We don’t “cherry pick” reports that support a particular position or opinion. We do not provide “evidence lite.” Our expert team of scientists and clinicians scrutinize the body of published, peer-reviewed literature to deliver critical appraisals of high-quality studies to our clients. The scientific rigor applied to this analysis allows us to produce reports of significant depth and breadth.
See a recording of our FREE Making the Grade Webinars for payers and providers:
I’m a provider. Why does this matter to me?
The move from fee-for-service to value-based medicine continues. With the current and future value-based purchasing and bundled payment initiatives taking root, supply chain and value analysis professionals will have an increasingly important role in helping their health systems achieve those outcome-based metrics while ensuring cost-effectiveness and physician engagement. This cannot be accomplished only with workflow tools or a “features and benefits” catalogue of medical products.
“The fact that we remain independent in our evaluations assists in improving your physician buy-in, especially in conversations of preference and cost-effectiveness.”
Unbiased evidence assessments are key in achieving these goals. Because we do not accept consulting engagements from manufacturers, you can rely on our reports to be free from vendor partiality. The fact that we remain independent in our evaluations assists in improving your physician buy-in, especially in conversations of preference and cost-effectiveness. Grounding clinical protocols and clinical technology selection decisions in evidence will insure quality outcomes and cost benefit. For example, evidence-based care bundles can significantly reduce the incidence of hospital-acquired infections (HAIs), a key metric in the domains of value-based purchasing (see our blog series, Evidence and Value-Based Purchasing for Value Analysis).
I’m a payer. Why does this matter to me?
There are a number of reasons why the depth of our HTAs are important to payers; not only the quality of the reports themselves, but the number of reports that we offer in our Knowledge Center. These reports include assessments of existing health technologies, but also those that are new to market, as well as those that are now being utilized for a new indication or patient population. This helps payers to stay current when being ask to consider coverage for an emerging or controversial procedure, test, or product.
“Our evidence assessments are so trusted by health plans, in fact, that consideration of our Ratings are imbedded in a large number of payers’ contract language.”
Additionally, the key to coverage defensibility is transparency. Because every one of our reports is so detailed and comprehensive, payers can make their coverage determinations with confidence, backed by our thoroughly scrutinized literature assessments, complete with our industry-standard Hayes Rating. Our evidence assessments are so trusted by health plans, in fact, that consideration of our Ratings are imbedded in a large number of payers’ contract language.
The reasons don’t stop there
We invite you to view two of our FREE recorded Making the Grade Webinars, each designed to speak to either the payer or provider market. Both Webinars will review a full Hayes report to give you detailed insight into the degree of scientific rigor that goes into our evidence assessment methodology. When you’ve finished the webinar, schedule a demo to see how Hayes can work for you.